{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:07:39Z","timestamp":1768885659705,"version":"3.49.0"},"reference-count":36,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.3892\/mmr.2017.6360","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T08:30:22Z","timestamp":1490257822000},"page":"3153-3160","source":"Crossref","is-referenced-by-count":10,"title":["Inhibition of farnesyl pyrophosphate synthase attenuates high glucose-induced vascular smooth muscle cells proliferation"],"prefix":"10.3892","volume":"15","author":[{"given":"Guo-Ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,3,23]]},"reference":[{"key":"key20180108015234_b1-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12265-012-9388-1","article-title":"Diabetic complications: Current challenges and opportunities","volume":"5","author":"Nickerson","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"key":"key20180108015234_b2-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/ATVBAHA.114.303522","article-title":"Recent highlights of ATVB: Diabetes mellitus","volume":"34","author":"Schmidt","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108015234_b3-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/CS20120413","article-title":"The vascular smooth muscle cell: A therapeutic target in type 2 diabetes?","volume":"125","author":"Porter","year":"2013","journal-title":"Clin Sci"},{"key":"key20180108015234_b4-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00109-014-1146-1","article-title":"The pathobiology of diabetic vascular complications-cardiovascular and kidney disease","volume":"92","author":"Gray","year":"2014","journal-title":"J Mol Med"},{"key":"key20180108015234_b5-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1194\/jlr.R800059-JLR200","article-title":"Diabetes and atherosclerosis: Is there a role for hyperglycemia?","volume":"50","author":"Chait","year":"2009","journal-title":"J Lipid Res"},{"key":"key20180108015234_b6-mmr-15-05-3153","first-page":"86","article-title":"The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis","volume":"39","author":"Rudijanto","year":"2007","journal-title":"Acta Med Indones"},{"key":"key20180108015234_b7-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.nbt.2012.07.001","article-title":"Farnesyl pyrophosphate synthase: A key enzyme in isoprenoid biosynthetic pathway and potential molecular target for drug development","volume":"30","author":"Dhar","year":"2013","journal-title":"N Biotechnol"},{"key":"key20180108015234_b8-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1517\/13543776.2011.593511","article-title":"Farnesyl pyrophosphate synthase modulations: A patent review (2006\u20132010)","volume":"21","author":"Sun","year":"2011","journal-title":"Expert Opin Ther Pat"},{"key":"key20180108015234_b9-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"key20180108015234_b10-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2007.03.016","article-title":"Mevalonate pathway: A review of clinical and therapeutical implications","volume":"40","author":"Buhaescu","year":"2007","journal-title":"Clin Biochem"},{"key":"key20180108015234_b11-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"379287","DOI":"10.1155\/2015\/379287","article-title":"Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: Possible role in high-glucose-induced atherogenic process","volume":"2015","author":"Chen","year":"2015","journal-title":"J diabetes Res"},{"key":"key20180108015234_b12-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: The first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"key20180108015234_b13-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.bcp.2010.08.015","article-title":"Chronic inhibition of Farnesyl pyrophosphate synthase improves endothelial function in spontaneously hypertensive rats","volume":"80","author":"Chen","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"key20180108015234_b14-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.RES.0000166924.31219.49","article-title":"Regulation of vascular smooth muscle cell proliferation: Role of NF-kappaB revisted","volume":"96","author":"Mehrhof","year":"2005","journal-title":"Circ Res"},{"key":"key20180108015234_b15-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1745-7254.2008.00855.x","article-title":"Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats","volume":"29","author":"Chen","year":"2008","journal-title":"Acta Pharmacol Sin"},{"key":"key20180108015234_b16-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0003-2697(86)90203-4","article-title":"Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions","volume":"157","author":"Lang","year":"1986","journal-title":"Anal Biochem"},{"key":"key20180108015234_b17-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1152\/japplphysiol.00096.2006","article-title":"Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats","volume":"102","author":"Zhu","year":"2007","journal-title":"J Appl Physiol (1985)"},{"key":"key20180108015234_b18-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijcard.2014.01.068","article-title":"Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis","volume":"172","author":"Xu","year":"2014","journal-title":"Int J Cardiol"},{"key":"key20180108015234_b19-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00109-012-0873-4","article-title":"Hydrogen sulfide: A gasotransmitter of clinical relevance","volume":"90","author":"Vandiver","year":"2012","journal-title":"J Mol Med (Berl)"},{"key":"key20180108015234_b20-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1471-4159.2010.06580.x","article-title":"Hydrogen sulfide as a gasotransmitter","volume":"113","author":"Gadalla","year":"2010","journal-title":"J Neurochem"},{"key":"key20180108015234_b21-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/CS20110267","article-title":"Emerging role of hydrogen sulfide in health and disease: Critical appraisal of biomarkers and pharmacological tools","volume":"121","author":"Whiteman","year":"2011","journal-title":"Clin Sci"},{"key":"key20180108015234_b22-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/ars.2013.5324","article-title":"Hydrogen sulfide and the pathogenesis of atherosclerosis","volume":"20","author":"Mani","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"key20180108015234_b23-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbrc.2010.04.061","article-title":"Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis","volume":"396","author":"Qiao","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108015234_b24-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cbf.1618","article-title":"Regulation of cardiovascular cell function by hydrogen sulfide (H(2)S)","volume":"28","author":"Elsey","year":"2010","journal-title":"Cell Biochem Funct"},{"key":"key20180108015234_b25-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.2174\/092986712801215928","article-title":"Hydrogen sulphide: Biopharmacological roles in the cardiovascular system and pharmaceutical perspectives","volume":"19","author":"Martelli","year":"2012","journal-title":"Curr Med Chem"},{"key":"key20180108015234_b26-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/ars.2011.4358","article-title":"Modulation of H(2)S metabolism by statins: A new aspect of cardiovascular pharmacology","volume":"17","author":"Beltowski","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"key20180108015234_b27-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"484269","DOI":"10.1155\/2014\/484269","article-title":"Paeonol inhibits proliferation of vascular smooth muscle cells stimulated by high glucose via Ras-Raf-ERK1\/2 signaling pathway in coculture model","volume":"2014","author":"Chen","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"key20180108015234_b28-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.regpep.2004.12.012","article-title":"Role of Ras\/PKCzeta\/MEK\/ERK1\/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation","volume":"128","author":"Zhao","year":"2005","journal-title":"Regul Pept"},{"key":"key20180108015234_b29-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10826060903558927","article-title":"Hyperglycemia induced cell growth and gene expression via the serum response element through RhoA and Rho-kinase in vascular smooth muscle cells","volume":"40","author":"Ishiko","year":"2010","journal-title":"Prep Biochem Biotechnol"},{"key":"key20180108015234_b30-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coph.2009.11.004","article-title":"Novel aspects of the roles of Rac1 GTPase in the cardiovascular system","volume":"10","author":"Sawada","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"key20180108015234_b31-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.freeradbiomed.2009.10.040","article-title":"Puerarin attenuates high-glucose and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2\/Rac1-dependent signaling","volume":"48","author":"Zhu","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"key20180108015234_b32-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","article-title":"Isoprenylated proteins","volume":"63","author":"McTaggart","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"key20180108015234_b33-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-291X(03)00323-1","article-title":"Protein prenylation: A pivotal posttranslational process","volume":"303","author":"Roskoski","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108015234_b34-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.7716512","article-title":"Protein lipidation in cell signaling","volume":"268","author":"Casey","year":"1995","journal-title":"Science"},{"key":"key20180108015234_b35-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0022-2143(96)90079-7","article-title":"Accumulation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits","volume":"127","author":"Ylitalo","year":"1996","journal-title":"J Lab Clin Med"},{"key":"key20180108015234_b36-mmr-15-05-3153","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0773.1998.tb01455.x","article-title":"Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro","volume":"83","author":"Ylitalo","year":"1998","journal-title":"Pharmacol Toxicol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2017.6360\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T03:48:41Z","timestamp":1515383321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.6360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,23]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,23]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.3892\/mmr.2017.6360"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.6360","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,23]]}}}